Business

Piper Sandler Maintains a Buy Rating on Soleno Therapeutics (SLNO), Sets a $145 PT

Oct 9, 2025 - 05:00
 1
Piper Sandler Maintains a Buy Rating on Soleno Therapeutics (SLNO), Sets a $145 PT
Read More

Related Posts

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025  4

The five keys to unlock homeownership for emerging buyers

The five keys to unlock homeownership for emerging buyers

Mar 21, 2025  0

London's Heathrow Airport to reopen after fire causes power outage

London's Heathrow Airport to reopen after fire causes p...

Mar 21, 2025  3

ZipRecruiter president David Travers sells $106,161 in stock

ZipRecruiter president David Travers sells $106,161 in ...

Mar 21, 2025  0

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

Mar 21, 2025  0

Airlines issue travel waivers due to London's Heathrow Airport shutdown

Airlines issue travel waivers due to London's Heathrow ...

Mar 21, 2025  0